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How NK cells and CTL kill their targets has been extensively investigated in
a number of laboratories (reviewed in references 1-7). These effector cells have
been shown to assemble tubular lesions on target cell membranes (8-10) . The
cytolytic apparatus of CTL lines (CTLL)' and cloned NK-like cells appears to
reside in the cytoplasmic granules. Granules isolated from these cells lyse target
cells and assemble ringlike lesions on their membranes (11-18). Recently, the
pore-forming protein (PFP, perforin) that mediates the formation of these
transmembrane tubuleshasbeen isolated (19-23). The isolated polypeptide lyses
tumor cells (23) and forms functional pores in lipid bilayers (20-23). It bears
structural, functional, and immunologic homologies with the ninth component
ofthe complement system (C9) (24, 25) and is actively secreted by murine CTLL
that have been stimulated with calcium ionophore (25). To date, the biochemical
analysis ofPFP/perforin has been conducted only on murine cell lines and cloned
cells. Although the use of cloned effector cells or cell lines has allowed the
expansion of large numbers of these cells in culture, greatly facilitating studies
on their lytic mechanisms, little is known about the lytic protein(s) of primary
cytotoxic effector cells. Moreover, a role for similar cytolytic protein(s) in the
killing mediated by human NK cells has not been established.
Resting mouse spleen (26) and human peripheral blood (27, 28) NK cells are
known to respond directly to the lymphocyte growth factor IL-2 with enhanced
spontaneous cytotoxic activity and, at later times, cell proliferation. The IL-2-
induced NK cells maintain the characteristic phenotype of fresh NK cells, and
no spontaneously cytotoxic cells are generated from other lymphocyte subsets in
short-term cultures in the presence of IL-2 (3, 28). The activation of cytotoxic
cells with IL-2 has recently generated wide interest in view of its potential
application in tumor immunotherapy (29). Here, we report on the identification
and isolation ofa 70,000-72,000 M,. polypeptide from human peripheral blood
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NK cells and a human NK cell line. The purified protein mediates the assembly
of functional and structural pores and shares antigenic crossreactivity with C9.
Our data suggest that this polypeptide may be generally involved in the cell-
tnediated killing and that the lytic event of both NK cells and CTL may develop
in a similar fashion .
Materials and Methods
Cell Lines.
￿
The human NK cell line NK3.3, derived from PBI, activated in primary
mixed lymphocyte culture (30), was kindly provided by Dr. J. Kornbluth, University of
Pennsylvania School of Medicine, Philadelphia. This IL-2-dependent cell line mediates
both spontaneous (30) and antibody-dependent cytotoxicity against tumor targets (our
unpublished data) and has surface phenotype of activated, proliferating NK cells. It bears
the low-affinity Fc receptor (FcR) for immune-complexed IgG (CD16 antigen) detected
by monoclonal antibodies B73.1 and 3G8 (unpublished), the 45-kD molecule correspond-
ing to the sheep erythrocyte receptor on T cells and most NK cells (CD2 antigen), the
30-32-kD antigen CD8, present on cytotoxic T lymphocytes and on a variable proportion
of NK cells, T10 and T200 antigens, and the 3A I and HLA-DR activation antigens (30).
None of the antigens present on the majority of T cells (i .e., the T cell receptor-associated
antigen CD3, CD5, a 60-kD molecule on T cells, and CD4, T helper-associated antigen)
is expressed on NK3 .3 cells, which are also negative for CD] 1 (receptor for C3bi, or CR3)
and Leu-7 (HNK-1) antigen (30). NK3 .3 cells were maintained in culture in Iscove's
medium (Gibco, Grand Island, NY), supplemented with 25 mM Hepes buffer, 10% heat-
inactivated pooled human serum (Bio-Bee, Boston, MA), and 15% IL-2-containing
leukocyte-conditioned medium (lymphocult-T, Biotest Serum Institute, Frankfurt, Fed-
eral Republic of Germany), as described (30).
The NK-sensitive human erythroinyeloid leukemia cell line K562, derived from a
patient with chronic myeloid leukemia in blast crisis (31) and the B lyinphoblastoid cell
line Daudi were maintained in culture in RPMI 1640 medium supplemented with 10%
FCS. These lines are mycoplasma-free on repetitive testing.
Antibodies.
￿
Production and characterization of the anti-CD16 antibody B73.1 (IgGI),
specific for the low-affinity FcR for aggregated IgG on NK cells and granulocytes (32-
34), B36 .1 (IgG2b, anti-CD2), and B33.1 (IgG2a, anti-HLA-DR nonpolymorphic deter-
minant) have been previously reported (35). The anti-CD16 antibody 3G8 (IgGI, refer-
ence 36) was a generous gift of Dr. J . Unkeless (Mount Sinai Medical School, New York);
and antibody N901 (IgG l) that reacted with NK cells, a subset of T cells, and some
immature myeloid cells (37) was kindly provided by Dr. J . Griffin (Dana Farber Cancer
Institute, Boston, MA). OKT3 (IgG2a, anti-CD3) (38) was produced in our laboratories
from cells obtained from American Type Culture Collection (Rockville, MD). Specific
polyclonal antibodies to reduced and alkylated human C9 were obtained as described (24,
25).
Peripheral Blood Cells and Lymphocyte Subsets.
￿
Venous peripheral blood drawn from
healthy donors was anticoagulated with preservative-free heparin, and mononuclear cells
were isolated by Ficoll-Hypaque gradient centrifugation (39). NK cells, NK cell-depleted
subsets, and -h cells were obtained from several different types of mononuclear cell
preparations: (a) mononuclear cells depleted of the majority of monocytes by one or two
cycles of adherence to plastic surfaces for 1 h at 37°(:; (b) mononuclear cells purified as
above from plateletphoresis bags obtained from New York Blood Center and depleted of
B cells and monocytes by eluting the plastic nonadlterent cells through a nylon wool
column (40); (c) when larger numbers of NK cells were needed, these were purified from
10-d cultures of PB1, with irradiated (50 Gy) Daudi cells in the absence of exogenously
added IL-2 . NK and T cells were purified from the above populations by indirect rosetting
with CrCI,,-treated goat anti-mouse Ig-coated erythrocytes (41) after sensitization with
the appropriate anti-NK (B73.1 or N901) or anti-T (B36.1, OK1'3) and anti-B (B33.1)
monoclonal antibodies as previously described (28, 32). To ensure maximal purification,
the rosetting procedure was repeated twice. When the lymphocyte subsets were obtainedLIU ET AL.
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by positive selection, contaminating erythrocytes were lysed using hypotonic medium (28,
32). In all cases, after purification, the cells were maintained in culture (10' cells/ml of
RPMI 1640 supplemented with 10% FCS) in a 5% C02 humidified atmosphere for 3 d
with purified human recombinant IL-2 (Genzyme, Boston, MA; or TGP-3, Takada
Chemical Industry, Inc., Osaka, Japan, a generous gift of Dr. T. Taguchi of Osaka
University, Japan) added at a final concentration of 40-50 U/ml. Purity of the cell
populations was tested by direct immunofluorescence using biotin-labeled monoclonal
antibodies to leukocyte subsets, detected with FITC-avidin as previously described (28,
32). The proportion of cells positive with the different antibodies was scored by flow
cytofluorometry on an Ortho Cytofluorograf 50H (Ortho Diagnostics, Westwood, MA)
connected to a Data General MP200 microprocessor.
Spontaneous Cytotoxicity Assays. These were performed in round-bottom microtiter
plates, using K562 cells as targets (10' cells/well) in a 3-h
51Cr-release assay as previously
described (32). Cytotoxic activity was quantitated from cytotoxicity curves obtained using
various E/T ratios by calculating the number of LU per 10' cells at 45% specific lysis with
the use of the linear regression to a modified von Krogh's equation (42). One LU is
defined as the number of effector cells that lyse 45% of the target cells within the test
time.
Biosynthetic Labeling ofCellswith [3'S]Methionine.
￿
The lymphocyte subsets were washed
three times with Dulbecco's phosphate-buffered saline (DPBS) and incubated (10' cells/
ml) for 18 h in methionine-free medium (using a kit obtained from Gibco), supplemented
with 4% RPMI 1640 medium and ["5S]methionine (New England Nuclear, Boston, MA)
(25 juCi/ml per 10' cells), containing 10% FBS and 15% IL-2-containing medium, both
previously dialyzed against PBS to remove residual methionine.
Affinity Purification of NK Cell PFP.
￿
An anti-human C9 immunoadsorbent was used
to purify PFP from cell lysates or from supernatants of cells treated with the calcium
ionophore A23187 . Both sources of PFP were adsorbed on 3G8-agarose (2 .2 mg of
3G8/g of agarose, 80% coupling efficiency) before PFP purification, to deplete the cell
preparations of FcR, and avoid its binding to the anti-C9 immunoadsorbent. To prepare
this latter immunoadsorbent, IgG of the rabbit anti-C9 antiserum were fractionated by
affinity chromatography using protein A-agarose (Boehringer Mannheim Biochemicals,
Indianapolis, IN). After alternate washes with PBS and PBS containing 0.4 M, NaCI
(PBS/NaCI), the agarose-bound IgG were eluted with 0.1 M glycine, pH 2 .5 . The eluate
was immediately neutralized with 10% fraction vol of 1 M Tris base and the eluted IgG
were coupled to glutardialdehyde-activated agarose (Boehringer Mannheim Biochemicals)
at 20 mg of protein per gram of agarose according to instructions provided by the
supplier. Coupling efficiency ranged from 70 to 90% .
Two different cell sources of PFP were used. (a) Cells (10'-1011 PBL subsets and NK3 .3
cells) were washed three times in DPBS at 4°C and resuspended to 107 cells/ml in ice-
cold lysis buffer (1 M NaKHP04, 10 mM benzamidine, 1 mM PMSF, 1 mM EDTA, 0 .5%
NP-40 [Calbiochem-Behring Corp., La Jolla, CA], pH 7 .4). After freezing and thawing
the cell suspension twice and sedimenting the nuclei and unbroken cells by low-speed
centrifugation (2,500 g, 5 min) the membrane-free lysate was obtained by centrifugation
at 350,000 g in a table-top ultracentrifuge (model TL-100, Beckman Instruments, Inc.,
Palo Alto, CA) for 30 min at 4°C. (b) Cells were washed and resuspended to 10' cells/ml
in DPBS containing 1 mM CaC12 at 37°C. Calcium ionophore A23187 (Calbiochem-
Behring Corp.) was added to 0 .5 uM final concentration, and the cell suspension was
incubated at 37°C for 20 min . Cells were pelleted by centrifugation (2,500 g, 15 min,
4°C). The cell-free supernatants from either preparation were applied to a column of 1
g of agarose coupled to specific antibodies to human C9. The column was washed and
the antigen was eluted as described above, with the exception of an additional wash with
PBS/0 .5% NP-40 before elution of the bound antigen.
Current Measurements.
￿
Solvent-free planar bilayers were formed from monolayers of
phospholipids according to Montal and Mueller (43), as described in detail elsewhere (44,
45). Acetone-extracted soybean phospholipids (46) were used to form the monolayers.
Positive current was defined as that following from cis to trans compartments, with the2064
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trans side defined as the virtual ground. Only bilayers with conductance that did not
exceed 10 pS and capacitance of 0.69-0.75 AF/cm2 were exposed to proteins. Proteins
were always introduced through the aqueous phase ofthe cis compartment. All recordings
were made at room temperature (22-24°C).
The cell proteins to be tested in bilayers were obtained by extracting plastic and nylon
wool-nonadherent PBL with lysis buffer without NP-40 and the supernatants obtained
after high-speed centrifugation were added directly to cis side. Affinity-purified PFP from
NK cell populations were solubilized first with 0.1 % Triton X-100 (Calbiochem-Behring
Corp.) and added to bilayers in small volumes, resulting in a detergent dilution exceeding
400-fold. Addition of the same volumes of detergent solutions alone did not induce any
conductance change in the bilayer.
Electron Microscopy.
￿
The eluate of anti-C9 affinity columns, containing PFP from NK
cells and PBL populations, was incubated with 30 mM ,#-D-octylglucoside (Calbiochem-
Behring Corp.) and 5 mM CaCl2 for 2-4 h at 37°C and placed on Formvar-coated 400-
mesh grids, stained with 2% phosphotungstic acid, pH 7, and examined under a JEOL
100 cx electron microscope QEOL USA, Electron Optics Div., Peabody, MA). To
incorporate PFP into liposomes, the eluate with detergent was sonicated with egg lecithin
(type V-E, Sigma Chemical Co., St. Louis, MO) at 3.3 mg/ml and liposomes were formed
by a one-step dilution protocol as outlined elsewhere (47). Proteoliposome suspensions
were examined by negative contrast as described above.
Light Microscopy.
￿
Cytocentrifuge smears of the cell preparations were stained with May
Grumwald-Giemsa at pH 8. Staining at this basic pH gave optimal preservation of the
granule morphology.
SDS-PAGE, Immunoblotting, and Fluorography.
￿
To define the biochemical characteris-
tics of the protein adsorbed on anti-C9 immunoadsorbent from ["S]methionine-labeled
cell lysates and from unlabeled cell lysates and supernatants, SDS-PAGE and immuno-
blotting were used respectively. 4-20% polyacrylamide gradient gels were prepared and
developed according to Laemmli (48), using "mini-gels" (casted using model 360, Bio-Rad
Laboratories, Richmond, CA). Gels were developed at constant current and the ones
containing radiolabel were soaked in autoradiography enhancer (EN'HANCE; New
England Nuclear) for 1 h, washed, dried under vaccum, and subjected to autoradiography.
Immunoblots were developed as described (49). NK cells were ruptured by freezing
and thawing, and the nucleus-free lysate was batch-adsorbed with 3G8-agarose (0.14 mg
of 3G8 per 10' cells) for 2 h at 4°C to remove FcR. The nonadsorbed material was then
electrophoresed under reducing conditions. Reduction and alkylation were performed
with 50 mM DTT and 0.1 M iodoacetamide. All samples were boiled for 5 min before
applying to gels. Protein transfer to nitrocellulose membranes (Millipore Corp., Bedford,
MA) was performed at constant current of 400 mA for 2.5 h. Anti-C9 antisera and pre-
immune serum control were used at a 1 :50 dilution and '21I-labeled goat F(ab')2 anti-
rabbit IgG (New England Nuclear) was used at 1 .2 ACi/ml as the secondary affinity label.
All washes were done with 10 mM Tris-HCI buffer, pH 7 .4, containing 0.4 M NaCl, 2
mM EDTA, 0.25% NP-40, and 0.25% Tween 20 (Bio-Rad Laboratories). The autora-
diography was always performed with intensifying screens.
For control, human C9 was also electrophoresed and immunoblotted with anti-C9
antibodies. C9 was purified from pooled human serum (New York Blood Center) accord-
ing to a previously published procedure (50), with the exception that serum proteins were
first eluted through a Sephacryl S-200 column before the hydroxyapatite column elution.
The purity of the C9 preparation was ascertained by SDS-PAGE and silver staining.
Results
Characteristics of NK Cells Isolated by Indirect Rosetting.
￿
NK cell populations
were purified by indirect rosetting using monoclonal antibodies directed against
either NK- or T cell-specific surface antigens. Although NK cells could be
isolated by either positive or negative selection, most experiments used the
negative selection procedure in order to avoid possible triggering ofcell degran-LIU ET AL.
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FIGURE 1 . Morphology of OKT3- NK cells separated from 10-d cultures separated by
indirect rosetting procedure (see Materials and Methods) . a and b correspond to two separate
experiments . Note the indented nucleus, the high cytoplasm/nucleus ratio, and the presence
of numerous cytoplasmic granules . X 400 .
ulation by the anti-NK cell antibodies . To obtain large numbers of cells for
biochemical analysis, PBL were cultured for 10 d with irradiated Daudi cells
before fractionation by negative selection using OKT3 . OKT3- cells purified
from these cultures have morphology of large granular lymphocytes (LGL) (51),
with high cytoplasm/nucleus ratios and containing azurophilic granules in their
cytoplasm (Fig . 1), like NK cells purified from fresh peripheral blood using
similarprocedures (not shown) . Thepurity oftheseNK cell preparations typically
exceeded 90%, as judged from their surface phenotypes (Fig . 2) . The OKT3-
cells express typical NK cell phenotype : they are CD16+ (Fig. 2), CD2+ and
N901 + (not shown) and do not express the T cell-associated markers CD5 (Fig .
2), CD4, and CD3 (not shown) . Unlike freshly obtained NK cells, they express
activation markers (HLA-DR, Tac antigen, and transferrin receptor) (not shown),
albeit at lower levels than NK cells cultured under similar conditions and
harvested on day 6 at the peak of their proliferation (52, 53) . The OKT3+
populations were largely depleted of NK cells, as assessed by surface markers
and lack of significant levels of spontaneous (Table 1, Fig . 3) and antibody-
dependent cytotoxicity . All NK cell subsets purified from fresh PBL (Fig . 3 a)
and from PBL cultured for 10 d with Daudi cells (Fig . 3 b) mediated spontaneous
(Fig . 3) and antibody-dependent cytotoxicity (not shown), whereas the OKT3+
subsets obtained from the same lymphocyte preparations and the NK cell-2066 HUMAN NATURAL KILLER CELL PORE-FORMING PROTEIN
FIGURE 2.
￿
Surface phenotype of PBL cultured for 10 d with irradiated Daudi cells. PBL
from one donor were cultured as described and NK cells were purified by negative selection
using OKT3 and indirect rosetting as described in Materials and Methods. The proportion of
cells positive forCD16 (B73.1) andCD2 (B36 .1) antigens was evaluated by direct immunoflu-
orescence (flow cytometry) using biotin-labeled B73.1 and B36.1 antibodies, respectively,
detected with FITC-avidin. (x axis) intensity of fluorescence; (y axis) number of cells. None
indicates the immunofluorescence of cells incubated with control irrelevant antibody and
FITC-avidin. Figures reported in each histogram are the proportion of cells positive with the
indicated antibodies.
C;ytotoxic Activity and Surface Phenotype of NK Cells Expanded In Vitro
TABLE I
* PBLwere cultured with irradiated Daudi cells for 10 d and the subsets were purified as described
in Materials and Methods.
$ Target cells were K562, in a 3-h 5'Cr-release assay.
§ LU (45%) per 107 cells, mean ± SD of eight experiments.
~~ Proportion of cells positive (direct immunofluorescence, flow cytometry), with theindicated biotin-
labeled antibodies. Mean ± SD of eight experiments.
Results from two separate experiments.
depleted subsets were virtually depleted of cells with spontaneous (Fig. 3 and
Table 1) and antibody-dependent cytotoxicity (not shown) .
Identification of the PFP in NK Cells.
￿
Previous reports (24, 25) have shown
that the mouse lymphocyte PFP/perforin and the human C9 are immunologically
related. The shared antigenic epitopes of these proteins are limited to cysteine-
rich domains that are exposed antigenically only when these proteins are chem-
ically reduced (24, 25). Here, we have used polyclonal antibodies derived against
human C9 to identify a C9-related polypeptide produced by human NK cells
(Fig. 4). The anti-C9 antibodies react with a unique polypeptide, contained in
peripheral blood NK cells but not T cells from the same PBL preparations, that
migrates with an Mf of 70,000-72,000 under reducing conditions (Fig. 4, lanes
4-6). The blots developed with preimmune serum did not react with the NK cell
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FIGURE 3.
￿
Spontaneous cytotoxic activity ofPBL subsets . Differentlymphocyte subsetswere
purified by indirect rosetting from (a) freshly obtained PBL or (b) PBL cultured for 10 d with
irradiated Daudi cells . Each PBL subset was tested for spontaneous cytotoxicity in a 3-h "Cr-
release assay against K562 targets . (X) total unseparated lymphocyte population; (L) OKT3+
cells ; (A) OKT3- cells ; (p) B73. I' cells ; (0) B73 .1- cells ; (p)N901* cells ; (" ) N901- cells .
FIGURE 4.
￿
Immunoblots of NK cell lysate proteins with anti-C9antiserum. Cell lysates were
prepared, as described in Materials and Methods, from several different PBL preparations .
Lanes 1 and 4: monocyte-depleted PBL. Lanes 2 and 5: B73 .1* cells purified from cultured
PBL. Lanes 3 and 6: N901 + cells purified from fresh cells . Lanes 7 and 8: C9, at 0 .29 jug per
lane . Lane 9: B73.1- cells purified from cultured PBL. Lane 10 : N901- cells purified from
fresh cells . Cell lysates were prepared andapplied at 1 .5 X 10 5 cell-equivalents per lane, except
for lanes 2 and 5, which contained lysate from 9 X 10" cells . Gels were developed under
reducing conditions . The autoradiography was performed overnight for all the samples.
lysate (lanes 1-3) . The M, . of this protein resembled that of purified C9 immu-
noblotted under the same conditions (Fig . 4, lane 8) . The same protein was not
found in OKT3+ and NK cell-depleted populations (Fig . 4, lanes 9 and 10),
pointing to the specificity of the immunologic crossreactivity between C9 and
NK PFP. The polypeptide identified on the immunoblot was not related to the
NK cell FcR (which could have bound to the agarose-linked immunoglobulins)
because all cell lysates had been preadsorbed with anti-FcR monoclonal 3G8-
agarose before gel electrophoresis of cell protein samples .
Isolation of the C9-related NK Cell PFP/Perforin .
￿
The C9-related NK cell PFP
was isolated by affinity chromatography using polyclonal anti-C9 antibodies as
the immunoadsorbent (see Materials and Methods) . Peripheral blood NK cells,2068
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FIGURE 5 .
￿
SDS-polyacrylamide gel profile of NK cell PFP purified by affinity chromatogra-
phy . OKT3- NK cells (8 X 10') were purified from 10-d cultures ofPBL and labeled with
["S]methionine as described in Materials and Methods . Labeled cells were stimulated with
A23187 and the cell-free supernatant was applied to an anti-C9 IgG-agarose column . 15 ,u1 of
the peak radioactivity fraction eluted from the column was applied to the lane . The autora-
diography was performed for 2 wk .
biosynthetically labeled with [s5S]methionine, were stimulated with A23187 in
the presence of Ca2' and the cell-free supernatant was applied to the anti-C9
affinity column . As expected, the antigen bound to and eluted from the affinity
column migrated with an M,- of 70,000-72,000 as analyzed by SDS-PAGE (Fig.
5) . The eluted radioactivity accounted for 3% of the total label found in the
cells . The C9-related polypeptide could also be isolated directly from cell lysates
of biosynthetically labeled NK cells by affinity chromatography . The isolated
polypeptide showed identical SDS-PAGE profile as that obtained from iono-
phore-stimulated cell supernatant and a similar 70,000-72,000 M, polypeptide
was identified also in the NK 3 .3 cell line which has been maintained in serum-
free medium (not shown) .
Ultrastructural Analysis of Tubular Lesions .
￿
The protein eluted from the anti-
C9 affinity column was incubated with ,B-D-octylglucoside at 37 °C for 2-4 h in
the presence ofCa2+ and examined by negative-contrast staining under electron
microscopy . Tubular lesions of various sizes (ranging 50-180 A) were observed
but the more frequently observed tubules had an internal diameter averaging
between 150 and 170 A (Fig . 6a). In addition to complete tubules, partially
assembled polymers were also seen . The protein/detergent mixture that had
been reconstituted into proteoliposomes (see Materialsand Methods) gave similar
morphology of lesions (Fig. 6, b-j) . Similar tubules were assembled by affinity-
purified PFP of human peripheral blood NK cells isolated by several different
protocols (Fig . 6, a-e) . Tubules were also formed by the PFP that had been
affinity-purified from NK3.3 cells (Fig . 6f). Thus, the lesions formed by affinity-
purified PFP ofNK cells resemble the previously reported lesions associated with
whole peripheral blood cells (8) .
Functional Channels Formed by Putative NK PFP/Perforin .
￿
The polypeptide
isolatedfrom the supernatants ofA23187-stimulatedOKT3-, N90I'and B73.1 +
cells lacked hemolytic activity and was not capable of inserting spontaneously
into planar bilayers to form ion channels . Similarresultswere obtained previously
with mouse CTLL (25), and were attributed to the rapid polymerization andLIU ET AL .
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FIGURE 6 .
￿
Morphology of ringlike lesions produced by the human NK cell PFP . Selected
images of affinity purified NK cell PFP assembled in the (a) absence or (bf) presence of lipid
vesicles andexamined by negative contrast (see Materials and Methods) . The PFPwas purified
from NK cells positively selected using (a and b) N901 and (c) 1373 .1 or negatively selected
using (d and e) OKT3 and (f) from NK3.3 cells . All NK cell subsets (a-c), with the exception
ofOKT3- (d and e), were obtained from fresh PBL .OKT3--selected cells were obtained from
10-d cultures ofPBL . Arrows point to longitudinal views of the tubules. The arrowhead in c
depicts a tubule inserted into the membrane of the lipid vesicle . Scale bar : 460 A.
inactivation of the cell released PFP in the extracellular medium, which contains
Cat+ . The affinity-purified PFP, however, could be incorporated into planar
lipid bilayers provided that the protein was solubilized first with detergent .
Because of their high impedance, planar bilayers are capable of resolving very
small current fluctuations associated with individual channel molecules . The
addition of affinity-purified protein (solubilized with 0.1% Triton X-100) re-
sulted in a progressive increase of membrane current, which occurred as a
summation of discrete current steps (Fig . 7a) . This behavior is indicative of
incorporation of individual or groups of channels into the lipid bilayer (54) .
Discrete steps ranging 0.3-1 nS were observed . The heterogeneity of channel
sizes was also exemplified by traces of single-channel fluctuations, which showed
large and heterogeneous unit conductances (Fig . 7, b and c) . The ionic channels
formed by this protein are highly resistant to closing by increasing voltages . To
induce channel closing, voltages exceeding 100 mV had to be applied (Fig. 7, b
and c) . This behavior resembles that observed for the mouse PFP/perforin
incorporated into the planar bilayer (18, 21, 23) . Ion channels of similar prop-
erties were formed by the polypeptides purified from NK3.3 cell line and
peripheral blood NK cell populations .
Ion selectivity ratios were obtained from the reversal potential necessary to
null the current flow from a 10-fold higher salt concentration with the cis
compartmentmade more concentrated . Permeability ratios of 1 :0.8:0.4:0 .2 were2070
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FIGURE 7.
￿
Effect of human NK cell PFPon planar lipid bilayers . Planar bilayers were formed
in 0.1 M NaCl, 1 mM CaCh, 5 mM Pipes, pH 7.4 . The bilayers were clamped at +30 mV in
a and +120 mV in b and c . The record in a was obtained from a chart recorder and b and c
were stored in a Nicolet 4094 digital oscilloscope . (a) NK cells were selected by using the
monoclonal antibody 1373 .1 . The 1373.1`and 1373 .1 - cells (from fresh PBL) were washed and
resuspended in lysis buffer without NP-40 (see Materials and Methods) at 10 7 cells/ml and
ruptured by freeze-thawing. 50 fal of the nucleus-free supernatant was applied to the aqueous
phase . Arrowhead and arrow indicate addition of 1373 .1 - and 1373 .1' cell supernatants,
respectively . Note the immediate rise in current in steps after addition ofproteins from B73. I'
cells . The current increased progressively until the membrane broke (small arrow on the
right) . The noise in the recording is due to stirring of the membrane chamber following
addition of proteins . (b) Affinity-purified NK cell PFP in 0.1% Triton X-100 (from 105 cell
equivalents of OKT3- cells of 10-d cultures of PBL) was applied to the bilayer and the
recording obtained 5 min later . The upward deflections indicate channel openings . (c) Same
material as in b incubated in the bilayer at 37°C for 2 h in the absence of detergent . The
material was then solubilized with 0.1% Triton X-100 and 10 5 cell-equivalents of material
were applied to the bilayer . A selected trace is shown . Note the closing of the channel to an
intermediate state prior to completely closing at the end of the record . Scale bars : (a) vertical,
60 pA, horizontal, 50 s; (b) vertical, 0 .24 nA, horizontal, 20 s ; (c) vertical, 80 pA, horizontal,
20s.
found for K'/Na'/Cl-/Ca" . The NK cell PFP-mediated channels were also
permeable to Mg" and Znz+ , indicative ofa lack of ion selectivity .
Discussion
NK cells are bone marrow-derived lymphocytes functionally defined by their
capability of lysing a wide variety of normal, virus-infected, and tumor-derived
target cells without prior sensitization (1, 3) . They bear a characteristic combi-
nation of surface differentiation antigens that serve to define them as a discrete
and homogeneous leukocyte subset, distinct from B and T lymphocytes and
rnyelomonocytic cells (3, 32) . Monoclonal antibodies have become useful in the
separation of this cell subset from otherPBL (32-34, 36) . Here we have separated
NK cell populations from fresh and cultured human PBL using several different
monoclonal antibodies in both positive and negative selection procedures .
Previous studies have characterized a cytolytic PFP (perforin) ofmouseCTLLLIU ET AL.
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and cell lines with NK-like activity (19-23). Here, we have identified a similar
polypeptide with an M,- of 70,000-72,000 (by SDS-PAGE) in human primary
NK cells and in a human NK cell line. Both freshly prepared human peripheral
blood NK cells and NK cells that have been stimulated with IL-2 in short-term
cultures contain PFP. This polypeptide, like the murine PFP, assembles func-
tional and structural lesions in target membranes. It shares immunologic cross-
reactivity with human C9 and has been purified by affinity chromatography
using anti-C9 antibodies bound to agarose as the immunoadsorbent. PFP is not
present in non-NK populations selected using monoclonal antibodies under the
same conditions and from the same PBL populations from which NK cells were
purified. PFP is not present in detectable amounts in fresh T cells, and its
production is increased in NK but not in T lymphocytes upon IL-2 treatment.
The T cells purified from the 10-d cultures of PBL bear markers of activated
lymphocytes, but unlike CTLL, lack PFP. These observations indicate that,
among lymphocytes, only NK cells are the predominant cells that constitutively
produce PFP, and suggest the possibility that PFP production by T cells may
require specific allogeneic stimulation.
The NK cell PFP is released from NK cellsafter direct stimulation with calcium
ionophore, suggesting that, like the PFP of murine CTLL, the PFP of human
primary NK cells may also be localized in secretory compartments (granules) of
their cytoplasm. During cell killing, this protein may be actively released and
concentrated in the intercellular space of contact between the NK cell and its
target, assembling thereafter into transmembrane tubules on the target surface.
Several observations support the contention that a secretory event may be
involved in NK cell-mediated killing: the lymphocyte Golgi apparatus and
microtubule organizing center become aligned toward the region of effector/
target contact (55, 56), and the cell granules translocate to the site of cell contact
(56, 57). The formation of large structural and functional pores by this protein
and its voltage resistance to closing would ensure that once this protein is inserted
into the target membrane, it would remain as an open transmembrane pathway,
allowing the free leakage of water, ions, and macromolecules across the plasma
membrane.
The human NK cell PFP is immunologically related to human C9 and has
been purified using polyclonal C9-specific antibodies. The nonreduced human
NK cell PFP reacts with anti-C9 antibodies, indicating that the shared antigenic
domain between human C9 and human NK cell PFP is not limited to a cysteine-
rich domain as in the case of human C9 and mouse PFP (24, 25). Several lines
of evidence indicate that the purified protein is not C9 : (a) the radioactivity of
the purified protein was derived from biosynthetically labeled cells and therefore
could not have been associated with contaminating C9 found in the serum; (b)
C9 polymerizes only after prolonged incubation (48-64 h) at temperatures
exceeding 37°C or in the presence of Zn2+ (24, 58, 59), in contrast to the rapid
polymerization observed here for the NK cell protein; (c) the tubules formed by
polymerized C9 have an internal diameter of 100 A (24, 58, 59) vs. the more
frequently observed diameter of 150-170 A observed here (Fig. 6); (d) NK cell-
depleted populations do not contain PFP/perforin (Fig. 4), reflecting the speci-
ficity of its cellular distribution . The purified polypeptide is also unrelated to the2072
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NK cell low-affinity FcRas adsorption with anti-FcR monoclonal antibodies does
not deplete the C9-related antigen from NK cell lysates.
The human NK cell PFP presents a number of biochemical, structural, and
functional properties that closely resemble the mouse CTL and NK cell-like
PFP/perforin (19-23). The observations suggest that a unique lytic polypeptide
is operative during cell killing mediated by both human and murine CTL and
NK cells. It is not clear whether other granule constituents may also play an
important role during cell killing. Other lytic mediators, such as proteases
(reviewed in reference 6) and NK cytolytic factors (60) have also been implied
in NK cell- and CTL-mediated killing of targets. It is conceivable that a channel
of the size described here could also function as a transmembrane conduit for
other toxic molecules (proteases, nucleases, and other cytolytic factors) that
might permeate through the target membrane. The permeation of a second
toxic mediator would explain the recently observed DNA fragmentation and
nucleus breakdown that appear to occur early during lymphocyte-mediated
killing (61). In this regard, it is noteworthy to point out that granules of murine
CTLL appear to contain tumor necrosis factor and lymphotoxin-like molecules
(Young, Liu, and Cohn, unpublished observations).
Pore formation may representageneral step in the mechanism ofcell-mediated
cytotoxicity, and has also been described for eosinophils (62) and the protozoan
parasite Entamoeba histolytica (44, 63-65). Interestingly both cell-derived (NK
PFP) and humoral (at least C9) immune mediators seem to share structural and
functional homologies. These observations indicate that these proteins may have
been derived from a common ancestral protein but have diverged during
evolution to become specialized for their respective effector roles in either
cellular or humoral immunity.
Summary
We show here that human peripheral blood NK cells contain a pore-forming
protein (PFP) with an M, of 70,000-72,000 that assembles structural lesions
(withan average internal diameter of 150-170 A) and forms functional channels .
The PFP was isolated by affinity chromatography from human NK cells, using a
specific anti-C9 antiserum as the immunoadsorbent. The NK cells were isolated
from PBL by positive or negative selection by indirect rosetting usinga panel of
monoclonal antibodies directed against different NK and T cell surface antigens.
PFP was identified in NK cells freshly isolated and isolated from cultured PBL,
both stimulated with interleukin 2, but not in NK cell-depleted lymphocytes. In
planar bilayers, the channels formed by the NK cell-derived PFP are highly
voltage resistant, with most channels persisting in the open state once they have
inserted into the bilayer. The unit conductances of these channels range 0.3-1
nS in 0.1 M NaCl . The channels show poor selectivity for monovalent and
divalent ions. The PFP is also released from human NK cells stimulated with the
calcium ionophore A23187, suggesting that this protein, like the one produced
by murine CTL lines, may be similarly secreted during cell-mediated killing. Its
identification in primary human NK cell cultures indicates that this protein may
play an active role in NK cell-mediated killing.We acknowledge initial collaborative studies with Dr. C. F. Nathan on murine primary
lymphocyte cultures. We also thank L. G. Leong and A. Damiano for excellent technical
assistance and Dr. J. Kornbluth for providing the NK 3 .3 cell line.
Receivedforpublication 31 July 1986.
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Note addedin proof: Zalman et al. (66) reported similar findings using unseparated LGL populations
stimulated with PHA and maintained in culture for 10 d with IL-2.
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